Tools commonly used in the Pulmonary & Respiratory Diseases industry for day-to-day tasks and operations.

• Spirometer
• Peak flow meter
• Oxygen concentrator
• Nebulizer
• Ventilator
• Bronchoscope
• Pulse oximeter
• Chest X-ray machine
• CT scanner
• MRI machine

Common products and services typical of NAICS Code 621111-17, illustrating the main business activities and contributions to the market.

• Asthma management
• COPD treatment
• Pneumonia diagnosis
• Lung cancer screening
• Tuberculosis management
• Pulmonary rehabilitation
• Sleep apnea treatment
• Cystic fibrosis management
• Pulmonary fibrosis diagnosis
• Bronchiectasis treatment

The specific certifications, permits, licenses, and regulatory compliance requirements within the United States for this industry.

• Respiratory Therapist License: A license required to practice respiratory therapy in the United States. The National Board for Respiratory Care (NBRC) provides the certification.
• Certified Asthma Educator (AE-C): A certification for healthcare professionals who provide asthma education to patients. The National Asthma Educator Certification Board (NAECB) provides the certification.
• Pulmonary Function Technologist Certification: A certification for healthcare professionals who perform pulmonary function tests. The National Board for Respiratory Care (NBRC) provides the certification.
• Registered Respiratory Therapist (RRT): A certification for respiratory therapists who have advanced knowledge and skills in respiratory care. The National Board for Respiratory Care (NBRC) provides the certification.
• Certified Respiratory Therapist (CRT): A certification for entry-level respiratory therapists. The National Board for Respiratory Care (NBRC) provides the certification.

A concise historical narrative of NAICS Code 621111-17 covering global milestones and recent developments within the United States.

• The history of the Pulmonary & Respiratory Diseases industry dates back to ancient times, where the Greeks and Romans used various herbs and plants to treat respiratory ailments. In the 19th century, the discovery of anesthesia and the invention of the stethoscope revolutionized the diagnosis and treatment of respiratory diseases. The 20th century saw significant advancements in the industry, including the development of antibiotics, vaccines, and inhalers. In recent years, the industry has seen a surge in research and development, with new treatments and therapies being developed to combat respiratory diseases such as asthma, COPD, and lung cancer. In the United States, the industry has been heavily impacted by the COVID-19 pandemic, with a significant increase in demand for respiratory equipment and treatments.

The anticipated future trajectory of the NAICS 621111-17 industry in the USA, offering insights into potential trends, innovations, and challenges expected to shape its landscape.

• Growth Prediction: Growing

  The future outlook for the Pulmonary & Respiratory Diseases industry in the USA is positive due to the increasing prevalence of respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), and lung cancer. The aging population and rising pollution levels are also contributing factors to the growth of this industry. The demand for respiratory devices and treatments is expected to increase, and technological advancements in the field of respiratory care are likely to drive growth. However, the industry may face challenges due to the high cost of treatment and the shortage of healthcare professionals in this field.

Recent groundbreaking advancements and milestones in the Pulmonary & Respiratory Diseases industry, reflecting notable innovations that have reshaped its landscape.

• Smart Inhalers: These inhalers are equipped with sensors that track medication usage and provide feedback to patients and healthcare providers, helping to improve adherence to treatment plans.
• Telemedicine: Remote consultations and monitoring of patients with respiratory diseases have become more common, allowing for more convenient and accessible care.
• Precision Medicine: Advances in genetic testing and personalized treatment plans are improving outcomes for patients with respiratory diseases.
• Immunotherapy: This treatment approach is showing promise in the treatment of lung cancer and other respiratory diseases.
• Wearable Technology: Devices such as smartwatches and fitness trackers can monitor respiratory rate and other vital signs, providing valuable data for patients and healthcare providers.